Scientific Revolutions: New Therapies Meet New Biology

3:00 PM - 4:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 253ABC

How have new understandings of cell biology, genomics, AI/ML based platform technologies expanded the druggable space to address hard-to-hit targets? What are the strategies and cutting edge/next generation biotech platforms that are being developed to push the current scientific boundaries and further expand the druggable space?

Moderator

Philip Sharp, PhD

Institute Professor

MIT and Intramural Faculty, Koch institute for Integrative Cancer Research

Speakers

Isaac Klein, MD, PhD

Chief Scientific Officer

Dewpoint Therapeutics

Richard Young, PhD

Professor of Biology

MIT and Core Member, Whitehead Institute

Giuseppe Ciaramella, PhD

President

Beam Therapeutics

Cigall Kadoch, PhD

Associate Professor of Pediatric Oncology; Harvard Medical School, Affiliate Faculty of Biological Chemistry and Molecular Biology; Institute Member and Epigenomics Program Co-Director

Dana-Farber Cancer Institute; Harvard Medical School; Broad Institute of MIT and Harvard